SCHEMBL19260258

SCHEMBL19260258

COC(=O)c1ccc(C(C)N2CCCc3cc(Cl)ccc32)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 5/20 0.77
HDAC6 Q9UBN7 5/20 0.77
IDO1 P14902 3/20 0.46
KCNH2 Q12809 3/20 0.46
HDAC8 Q9BY41 2/20 0.45
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45
NCOR2 Q9Y618 1/20 0.45
MAPT P10636 2/20 0.45
TP53 P04637 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PDK1 Q15118 1/20 0.43
PDK2 Q15119 1/20 0.43
PDK3 Q15120 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19260248 0.87 HDAC1 (1.00) HDAC1HDAC6IDO1KCNH2HDAC8
SCHEMBL19278655 0.77 HDAC1 (0.73) HDAC1HDAC6HDAC8HDAC3HDAC4
SCHEMBL1576161 0.74 HDAC1 (0.59) HDAC1HDAC6IDO1KCNH2HDAC8
SCHEMBL1576159 0.74 HDAC1 (0.59) HDAC1HDAC6IDO1KCNH2HDAC8
SCHEMBL12719258 0.73 HDAC1 (0.58) HDAC1HDAC6IDO1KCNH2HDAC8
SCHEMBL17169813 0.73 HDAC1 (0.56) HDAC1HDAC6IDO1KCNH2HDAC8
SCHEMBL1576392 0.72 HDAC1 (0.57) HDAC1HDAC6IDO1KCNH2HDAC8
SCHEMBL1576541 0.72 HDAC1 (0.57) HDAC1HDAC6IDO1KCNH2HDAC8
SCHEMBL13981019 0.72 HDAC1 (0.57) HDAC1HDAC6IDO1KCNH2HDAC8
SCHEMBL2626574 0.72 HDAC1 (0.54) HDAC1HDAC6IDO1KCNH2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3416633-B1 TETRAHYDROQUINOLINE SUBSTITUTED HYDROXAMIC ACIDS AS SELECTIVE HISTONE DEACETYLASE 6 INHIBITORS UNIV ILLINOIS (US) 2025-07-23 EP disclosed
US-10456394-B2 Tetrahydroquinoline substituted hydroxamic acids as selective histone deacetylase 6 inhibitors THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2019-10-29 US disclosed
US-20190255046-A1 TETRAHYDROQUINOLINE SUBSTITUTED HYDROXAMIC ACIDS AS SELECTIVE HISTONE DEACETYLASE 6 INHIBITORS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOS (US) 2019-08-22 US disclosed
EP-3416633-A1 TETRAHYDROQUINOLINE SUBSTITUTED HYDROXAMIC ACIDS AS SELECTIVE HISTONE DEACETYLASE 6 INHIBITORS The Board of Trustees of the University of Illinois (US) 2018-12-26 EP disclosed
WO-2017142883-A1 TETRAHYDROQUINOLINE SUBSTITUTED HYDROXAMIC ACIDS AS SELECTIVE HISTONE DEACETYLASE 6 INHIBITORS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2017-08-24 WO disclosed
WO-2017142883-A1 TETRAHYDROQUINOLINE SUBSTITUTED HYDROXAMIC ACIDS AS SELECTIVE HISTONE DEACETYLASE 6 INHIBITORS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2017-08-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190255046-A1 TETRAHYDROQUINOLINE SUBSTITUTED HYDROXAMIC ACIDS AS SELECTIVE HISTONE DEACETYLASE 6 INHIBITORS HDAC1, HDAC5, HDAC7 HDAC1 1/4885HDAC6 8/4885IDO1 391/4885
US-10456394-B2 Tetrahydroquinoline substituted hydroxamic acids as selective histone deacetylase 6 inhibitors HDAC1, HDAC5, HDAC7 HDAC1 1/4885HDAC6 8/4885IDO1 391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.